The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies
Top Cited Papers
- 31 July 2010
- journal article
- review article
- Published by Elsevier BV in Neuroscience & Biobehavioral Reviews
- Vol. 34 (8), 1307-1350
- https://doi.org/10.1016/j.neubiorev.2010.04.001
Abstract
No abstract availableKeywords
This publication has 338 references indexed in Scilit:
- Mode shifting between storage and recall based on novelty detection in oscillating hippocampal circuitsHippocampus, 2004
- Effects of low-dose scopolamine on locomotor activity: No dissociation between cognitive and non-effectsNeuroscience Research Communications, 2002
- Simple and conditional discriminations in rats: The effects of delays and scopolamineLearning and Motivation, 1987
- Selectivity of pirenzepine in the central nervous system. II. Differential effects of pirenzepine and scopolamine on performance of a representational memory taskBrain Research, 1987
- Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in ratsPsychopharmacology, 1985
- Cholinergic mechanisms in the production of focal cortical slow wavesCellular and Molecular Life Sciences, 1982
- Cholinergic blockade of the caudate nucleus and spatial alternation performance in rats: Overtraining induced protection against behavioral deficitsLife Sciences, 1978
- Effects of physostigmine and scopolamine on operant brightness discrimination in the ratPhysiology & Behavior, 1972
- Amnesic properties of scopolamine and brain acetylcholine in the ratInternational Journal of Neuropharmacology, 1965
- Geburten in künstlichem DämmerschlafArchiv für Gynäkologie, 1906